aDanaparoid is no longer marketed in some of these countries, e.g., United States, Norway, and Denmark. bOrthopedic and general surgery only (unless otherwise indicated); approval includes starting danaparoid 1-4 h preoperatively (except for United States). "Elective hip surgery only. dOrthopedic and cancer surgery only.

eApproval modified to facilitate approval for HIT in Finland and Germany. fApproved for the treatment of DIC.

Abbreviations: DIC, disseminated intravascular coagulation; DVT, deep vein thrombosis; HIT, heparin-induced thrombocytopenia.

thrombocytopenia or thrombosis during treatment with danaparoid, although the implications of a positive result remain uncertain.

0 0

Post a comment